Form 4 for MDXG MIMEDX GROUP, INC.
Accepted 2022-04-12 00:00:00 ET · period of report 2022-04-08 · accession 0001376339-22-000045 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-12 | 2022-04-08 | MDXG | WRIGHT TIMOTHY R | CEO, Dir | A - Grant | $4.62 | +602.7K | 1.82M | +49% | +$2.78M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-08 | A | A | 602,679 | $4.62 | 1,823,324 | D | — | — | (F1) Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years. Grant is exempt under Rule 16b-3. |